NYBC Ventures
Venture capitalBoston · Seed–Series A · 4 people tracked
Investment thesis
NYBC Ventures is an early-stage investment fund that focuses on blood and cellular therapies, as well as related therapeutic devices and technologies. The firm operates in the life sciences sector.
Team · 4 people
from the firm's websiteFrequently asked questions
- What stage does NYBC Ventures invest at?
- NYBC Ventures invests at the Seed, Series A stages.
- What sectors does NYBC Ventures focus on?
- NYBC Ventures focuses on Biotech, Medical Devices.
- Where is NYBC Ventures located?
- NYBC Ventures is headquartered in Boston, US.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.